BioWorld MedTech

July 27, 2011

Combination of molecular tests best at detecting thyroid cancer

ATLANTA — A picture displaying what appears to be part of a female's abdomen pops up on the screen – with the words next to it "The fastest growing cancer among women isn't what you think." (Medical Device Daily) Read More

Studies support Cellvizio use in GI, urology, and more

Report from Europe: First five patients treated in TriVascular's OVATION trial

Washington roundup: FDA's 'when-to-file' guidance limits predicates to those cited

Financings roundup: HCA to offer $1 billion of its secured and unsecured notes

MDD's food for med-tech thought

Deals roundup: OraSure buys DNA Genotek for close to $53M in cash

Agreements/contracts: CareFusion to distribute ResMed Stellar ventilators

HIT roundup: New mobile app to help decipher medical tests

Med-Tech Notes

People in the News

Product Briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for July 31, 2026.

Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors

BioWorld Science

Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...

Silhouette illustration of DNA gene editing

Death in Chinese gene-editing trial exposes ethical fault lines

BioWorld

The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...

Seed funding at Adjuvia to treat mitochondrial dysfunction

BioWorld Science

Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...

Replimune’s RP-1 for melanoma wins over FDA adcom

BioWorld

Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...